Colorectal cancer is becoming more common among younger adults. Screening guidelines have evolved to reflect that.

Tumor cells in colorectal cancer exploit an important signaling pathway that normally controls embryo development.

Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify ...

Plus, new clues about the rise in colorectal cancer rates in young adults. You are reading our weekly Well+Being newsletter.

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

Health officials in Newfoundland and Labrador have announced residents can now self-refer for colon and breast cancer ...

Researchers aimed to increase colorectal cancer screening rates among patients aged 45 to 64 years at a primary care clinic.

Colorectal cancer is the fourth most common cancer in the U.S. and the second leading cause of cancer death. But there are ...

Avoiding smoking, eating a high-fiber diet and routine screenings are key to reducing the risk of recurrence in colorectal or anal cancer.

Alcohol associated cancer deaths have doubled in the U.S. over the past three decades, disproportionately impacting men and people 55 and older.

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...

Cancer took just about everyone in journalist Larry Ingrassia’s family, except him. His book unpacks his family’s multi-generational cancer mystery.